Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO)

68 filings reported holding MREO - Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares as of Q1 2023.
Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 60.8M shares of 791M outstanding shares and own 7.69% of the company stock.
Largest 10 shareholders include Rubric Capital Management LP (10.4M shares), ORBIMED ADVISORS LLC (7.75M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (7.36M shares), Rock Springs Capital Management LP (6.24M shares), CITADEL ADVISORS LLC (3.05M shares), MILLENNIUM MANAGEMENT LLC (2.51M shares), Tejara Capital Ltd (2.44M shares), ALKEON CAPITAL MANAGEMENT LLC (2.39M shares), GOLDMAN SACHS GROUP INC (2.26M shares), and Boxer Capital, LLC (2.25M shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.